News

Leadership Transition at electroCore: Errico Steps Up

Leadership Transition at electroCore: Errico Steps Up

electroCore Announces New Leadership Changes

electroCore, Inc. (Nasdaq: ECOR) recently announced significant leadership changes within its board of directors, marking a new chapter for the company. The departure of Peter Cuneo has opened the door for Dr. Thomas J. Errico to step in as Chairman. This transition reflects electroCore's commitment to continued growth and innovation in bioelectronic medicine.

Farewell to Peter Cuneo

Over the years, Peter Cuneo has been an instrumental figure at electroCore, providing valuable insights and support as a member of the Board since 2020 and as Chairman since 2021. During his tenure, he played a pivotal role in propelling electroCore to new heights, helping to steer the company through challenging periods. Dan Goldberger, CEO of electroCore, expressed his gratitude for Cuneo's dedicated service and influence, emphasizing the positive impact he has had on the organization.

A Legacy of Leadership

The contributions made by Cuneo extend beyond mere governance; his strategic guidance has been a beacon for the company, aligning with the interests of shareholders and the broader management team. As Cuneo transitions to a role as a strategic advisor, his experience will continue to benefit electroCore's strategic vision.

Introducing Dr. Thomas J. Errico

Dr. Errico, a co-founder of electroCore, has been committed to the company's mission since its inception. His extensive background in the bioelectronic field positions him well to lead as the new Chairman. Goldberger highlighted Errico's significant contributions as the Chairman of the Nominating and Governance Committee, stressing that his leadership will enhance the company's strategic direction moving forward.

Dr. Errico's Vision for the Future

With Errico at the helm, electroCore aims to forge ahead with its dual prescription products, namely gammaCore and Quell. Both treatments leverage cutting-edge non-invasive technologies aimed at managing chronic pain. The addition of Errico signifies a refreshing perspective and renewed energy to advance these innovative solutions in the market.

About electroCore, Inc.

Founded with the vision of transforming healthcare through bioelectronic technologies, electroCore, Inc. is dedicated to improving quality of life. The company's flagship products not only address medical conditions but also enhance wellness for users. As they continue to expand their product offerings, electroCore remains focused on utilizing bioelectronic technology to create tools that empower individuals in managing their health.

Innovations in Bioelectronic Medicine

The utilization of non-invasive bioelectronic techniques is revolutionizing how chronic pain and wellness are approached. With products like gammaCore and Quell, electroCore is at the forefront of this medical innovation, offering patients effective solutions that integrate seamlessly into their daily lives.

Frequently Asked Questions

What leadership change has electroCore announced?

electroCore has announced the departure of Peter Cuneo from its Board of Directors, with Dr. Thomas J. Errico elected as the new Chairman.

What was Peter Cuneo's role in the company?

Peter Cuneo served as a Board member and Chairman, providing leadership and strategic guidance since 2020.

Who is Thomas J. Errico?

Thomas J. Errico is a co-founder of electroCore and has served on the board, bringing valuable experience to his role as Chairman.

What products does electroCore offer?

electroCore offers gammaCore and Quell, which are non-invasive devices designed to treat chronic pain through bioelectronic technology.

How does electroCore plan to innovate in the future?

Under Dr. Errico's leadership, electroCore aims to enhance its product offerings and continue to lead in bioelectronic health solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 62

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Color Me Mine Tests Florida's Creative Leisure Demand

Updated Category News Views 72

Pottery studios are not exactly the sort of thing that makes markets pound the table, but Florida’s latest Color Me Mine push deserves a closer look. The company signed three franchise agreements in 2026 for Panama City Beach, Doral and Boca Raton, adding planned growth to a state where it already operates 11 studios. For a private franchisor, this is not a quarterly...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 151

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 170

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 75

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 175

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 69

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
Emaar's Huspy Deal Brings Financing Into Home Sales

Updated Category News Views 87

Mortgage paperwork is nobody’s idea of luxury, yet it can wreck a property sale faster than a bad floor plan. Emaar Properties has partnered with Dubai-based Huspy to give its customers access to mortgage advice and financing comparisons from more than 20 UAE banks. It is not a flashy tower launch or a headline-grabbing land purchase. Frankly, that is why investors...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 160

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading

Top 5 Most Recently Viewed Articles

How the Bank of England's Interest Rate Decision Impacts Your Investments

Updated Category Economy Views 316

Introduction The Bank of England's decision on interest rates plays a critical role in shaping the economic landscape, with far-reaching effects on your investment portfolio. Changes in these rates can influence stock market performance, affect bond yields, and alter the attractiveness of various asset classes. Understanding how these adjustments can impact your...

Continue Reading
Eric Beightel Joins Environmental Science Associates Team

Updated Category News Views 131

Eric Beightel Appointed as Federal Strategy Director Environmental Science Associates (ESA) is thrilled to welcome Eric Beightel to its team as the new Federal Strategy Director. With a comprehensive background in environmental policy, Beightel brings a wealth of knowledge to ESA, poised to enhance its capabilities in navigating the complexities of federal regulations....

Continue Reading
iBio Inc. Showcases Innovative Antibody Developments Soon

Updated Category News Views 257

Exciting Presentations from iBio Inc. iBio, Inc. (NASDAQ: IBIO), a pioneering biotechnology company, is gearing up to present breakthrough research on its Activin E antibody. This development showcases its commitment to addressing critical health challenges like obesity. Recently, Cory Schwartz, Ph.D., the Director of Research and Early Development at iBio, announced his...

Continue Reading
Turkey's Markets Experience A Dip as Investors React

Updated Category News Views 319

A Dip in Turkey's Stock Market Performance Turkey's stock market witnessed a decline recently, with shares closing lower on the exchange. The BIST 100 index, a benchmark for investors, finished down by 0.60%, indicating a challenging trading day for stakeholders. Sectors Impacting Market Trends Leading the Declines A noticeable drop in market values was driven by several...

Continue Reading
Medline Celebrated for Innovation in Respiratory Care Solutions

Updated Category News Views 180

Medline secured the prestigious Zenith Award from the American Association for Respiratory Care (AARC) in 2024, marking a significant moment for traders and healthcare pros alike. This award wasn’t just handed out; it was earned by only eight companies out of over 300 nominees. The kind of spotlight that draws attention can shake up market sentiments. Why Medline Stood...

Continue Reading